154 related articles for article (PubMed ID: 38419511)
1. Evaluation of Ultrathin Strut Biodegradable Polymer-Coated Sirolimus-Eluting Stents in an All-Comers Patient Population: 1-Year Results of the S-FLEX Slovakia Registry.
Hudec M; Kupec A; Gazdic P
Anatol J Cardiol; 2024 Mar; 28(3):142-149. PubMed ID: 38419511
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes of ultrathin biodegradable polymer-coated sirolimus-eluting stents in an all-comer population: One-year results from the T-FLEX registry including high-risk subgroups.
Pothineni RB; Vijan V; Potdar A; Inamdar MK; Pathak A; Mantravadi SS; Ajmera P
Anatol J Cardiol; 2021 Oct; 25(10):706-715. PubMed ID: 34622785
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes in 995 unselected real-world patients treated with an ultrathin biodegradable polymer-coated sirolimus-eluting stent: 12-month results from the FLEX Registry.
Lemos PA; Chandwani P; Saxena S; Ramachandran PK; Abhyankar A; Campos CM; Marchini JF; Galon MZ; Verma P; Sandhu MS; Parikh N; Bhupali A; Jain S; Prajapati J
BMJ Open; 2016 Feb; 6(2):e010028. PubMed ID: 26888727
[TBL] [Abstract][Full Text] [Related]
4. Prospective evaluation of an ultrathin strut biodegradable polymer-coated sirolimus-eluting stent: 12 months' results from the S-FLEX UK registry.
Choudhury A; Garg S; Smith J; Sharp A; Nabais de Araujo S; Chauhan A; Patel N; Wrigley B; Chattopadhyay S; Zaman AG
BMJ Open; 2019 Oct; 9(10):e026578. PubMed ID: 31604782
[TBL] [Abstract][Full Text] [Related]
5. Real-World Use Of Ultrathin-Strut Biodegradable Polymer-Coated Sirolimus-Eluting Stents In Patients With Coronary Artery Disease: 6-Month Clinical Outcomes.
Ajmera P; Pothineni R; Chawla KK; Mantravadi SS; Jariwala PV; Vijan V; Vijan V
Vasc Health Risk Manag; 2019; 15():439-447. PubMed ID: 31695399
[TBL] [Abstract][Full Text] [Related]
6. One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in diabetic patients: Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry).
Beneduce A; Ferrante G; Ielasi A; Pivato CA; Chiarito M; Cappelletti A; Baldetti L; Magni V; Prati E; Falcone S; Pierri A; De Martini S; Montorfano M; Parisi R; Rutigliano D; Locuratolo N; Anzuini A; Tespili M; Margonato A; Benassi A; Briguori C; Reimers B; Fabbiocchi F; Bartorelli A; Colombo A; Godino C
Catheter Cardiovasc Interv; 2020 Aug; 96(2):255-265. PubMed ID: 31905259
[TBL] [Abstract][Full Text] [Related]
7. Sirolimus-eluting stents with ultrathin struts versus everolimus-eluting stents for patients undergoing percutaneous coronary intervention: final three-year results of the TALENT trial.
de Winter RJ; Zaman A; Hara H; Gao C; Ono M; Garg S; Smits PC; Tonino PAL; Hofma SH; Moreno R; Choudhury A; Petrov I; Cequier A; Colombo A; Kaul U; Onuma Y; Serruys PW
EuroIntervention; 2022 Aug; 18(6):492-502. PubMed ID: 35285804
[TBL] [Abstract][Full Text] [Related]
8. 1-Year Clinical Outcomes of All Comers Treated With 2 Bioresorbable Polymer-Coated Sirolimus-Eluting Stents: Propensity Score-Matched Comparison of the COMBO and Ultrathin-Strut Orsiro Stents.
Chandrasekhar J; Kok MM; Kalkman DN; Aquino MB; Zocca P; Woudstra P; Beijk MA; Kerkmeijer LS; Sartori S; Baber U; Tijssen JG; Koch KT; Dangas GD; Colombo A; Pocock S; von Birgelen C; Mehran R; de Winter RJ;
JACC Cardiovasc Interv; 2020 Apr; 13(7):820-830. PubMed ID: 32273094
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of the latest generation biodegradable polymer-coated ultrathin sirolimus-eluting stent in the treatment of coronary artery disease in a European all-comer population with or without high bleeding risk: The Cruz HBR Registry.
Leistner DM; Rampat R; Haude M; Schmitz T; Allali A; Möllmann H; Stähli BE; Rudolph TK; Lauten A; Koning R; Bogaerts K; Sudhir K; Naber C
Minerva Cardiol Angiol; 2024 Aug; 72(4):355-365. PubMed ID: 38804621
[TBL] [Abstract][Full Text] [Related]
10. [Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent for the treatment of de novo coronary lesions: 5-year results of the TARGET Ⅱ trial].
Xu LJ; Gao Z; Song Y; Wang HH; Xu JJ; Gao LJ; Zhang Y; Song L; Zhao XY; Chen J; Yuan JQ; Qiao SB; Yang YJ; Xu B; Gao RL;
Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Jul; 46(7):523-528. PubMed ID: 30032542
[No Abstract] [Full Text] [Related]
11. Safety and Clinical Performance of Biodegradable Polymer-Coated Ultra-Thin Everolimus-Eluting Stents in "Real-World" Patients: A Multicenter Registry (PERFORM-EVER).
Kasturi S; Polasa S; Sowdagar MA; Kumar P; Reddy T; Nichenamatla C; Singh S; Reddy V
Anatol J Cardiol; 2022 Aug; 26(8):619-628. PubMed ID: 35924288
[TBL] [Abstract][Full Text] [Related]
12. Three-Year Outcomes of Biodegradable Polymer-Coated Ultra-Thin (60 µm) Sirolimus-Eluting Stents in Real-World Clinical Practice.
Chandwani P; Meel B; Singhal R; Jangid K; Ahmed R; Yadav M; Gupta AK; Chopra R
Ann Acad Med Singap; 2019 May; 48(5):150-155. PubMed ID: 31210252
[TBL] [Abstract][Full Text] [Related]
13. Safety and Performance of the Orsiro Sirolimus-Eluting Stent in the Treatment of All-Comers Patient Population in Daily Clinical Practice.
Boukhris M; Potter BJ; Fam NP; Matteau A; Graham JJ; Gobeil F; Hillani A; Kutryk M; Mansour S
Cardiovasc Revasc Med; 2020 Nov; 21(11):1348-1354. PubMed ID: 32354583
[TBL] [Abstract][Full Text] [Related]
14. Thin, Very Thin, or Ultrathin Strut Biodegradable or Durable Polymer-Coated Drug-Eluting Stents: 3-Year Outcomes of BIO-RESORT.
Buiten RA; Ploumen EH; Zocca P; Doggen CJM; Danse PW; Schotborgh CE; Scholte M; van Houwelingen KG; Stoel MG; Hartmann M; Tjon Joe Gin RM; Somi S; Linssen GCM; Kok MM; von Birgelen C
JACC Cardiovasc Interv; 2019 Sep; 12(17):1650-1660. PubMed ID: 31422087
[TBL] [Abstract][Full Text] [Related]
15. Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents: BIOFLOW V Final 5-Year Outcomes.
Kandzari DE; Koolen JJ; Doros G; Garcia-Garcia HM; Bennett J; Roguin A; Gharib EG; Cutlip DE; Waksman R;
JACC Cardiovasc Interv; 2022 Sep; 15(18):1852-1860. PubMed ID: 36137689
[TBL] [Abstract][Full Text] [Related]
16. Five-Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents.
Iglesias JF; Heg D; Roffi M; Tüller D; Lanz J; Rigamonti F; Muller O; Moarof I; Cook S; Weilenmann D; Kaiser C; Cuculi F; Valgimigli M; Jüni P; Windecker S; Pilgrim T
J Am Heart Assoc; 2019 Nov; 8(22):e013607. PubMed ID: 31696762
[TBL] [Abstract][Full Text] [Related]
17. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S
JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698
[TBL] [Abstract][Full Text] [Related]
18. A prospective multicentre randomised all-comers trial to assess the safety and effectiveness of the thin-strut sirolimus-eluting coronary stent SUPRAFLEX: rationale and design of the Thin Strut Sirolimus-eluting Stent in All Comers Population vs Everolimus-eluting Stent (TALENT) trial.
Modolo R; Chichareon P; Kogame N; Asano T; Chang CC; de Winter RJ; Kaul U; Zaman A; Spitzer E; Takahashi K; Katagiri Y; Soliman OII; van Es GA; Morel MA; Onuma Y; Serruys PW
EuroIntervention; 2019 Jul; 15(4):e362-e369. PubMed ID: 30066672
[TBL] [Abstract][Full Text] [Related]
19. Thin Composite-Wire-Strut Zotarolimus-Eluting Stents Versus Ultrathin-Strut Sirolimus-Eluting Stents in BIONYX at 2 Years.
Buiten RA; Ploumen EH; Zocca P; Doggen CJM; Jessurun GAJ; Schotborgh CE; Roguin A; Danse PW; Benit E; Aminian A; van Houwelingen KG; Schramm AR; Stoel MG; Somi S; Hartmann M; Linssen GCM; von Birgelen C
JACC Cardiovasc Interv; 2020 May; 13(9):1100-1109. PubMed ID: 32381186
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Clinical Outcomes Following Single versus Multivessel Percutaneous Coronary Intervention Using Biodegradable Polymer Coated Sirolimus-Eluting Stent in an All-comers Patient Population.
Chandwani P; Verma P; Saxena S; Ramachandran PK; Abhyankar A; Sandhu MS; Parikh N; Bhupali A; Jain S; Prajapati J
Cardiovasc Hematol Agents Med Chem; 2016; 14(1):39-48. PubMed ID: 26585397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
